
Use of antitussive medications in acute cough in young children
Author(s) -
Lam Samuel H. F.,
Homme James,
Avarello Jahn,
Heins Alan,
Pauze Denis,
Mace Sharon,
Dietrich Ann,
Stoner Michael,
Chumpitazi Corrie E.,
Saidinejad Mohsen
Publication year - 2021
Publication title -
journal of the american college of emergency physicians open
Language(s) - English
Resource type - Journals
ISSN - 2688-1152
DOI - 10.1002/emp2.12467
Subject(s) - medicine , common cold , medical prescription , over the counter , complaint , food and drug administration , adverse effect , intensive care medicine , pediatrics , pharmacology , political science , law , immunology
Acute cough, a common complaint in young children, is often the result of a viral upper respiratory infection. Cough and cold remedies generate billions of dollars in annual sales in the United States, despite a lack of evidence of their efficacy and multiple warnings by the US Food and Drug Administration. The current article begins with the best available evidence for common over‐the‐counter (OTC) and prescription antitussive remedies in children. The article concludes with a discussion of the pros and cons for the use of antitussives in children with cough. In general, OTC antitussive medications should not be routinely used in children under 2 years of age. In certain cases, antitussives with minimal adverse profile and some evidence of benefit may be recommended after informed counseling.